Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Anastrozole in Metastatic Breast Cancer
NCT00217399Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in breast cancer, sponsored by National Cancer Institute. Started Jun 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00217399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217399.